144 related articles for article (PubMed ID: 31606743)
1. Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
Chateau T; Angioi K; Peyrin-Biroulet L
J Crohns Colitis; 2020 May; 14(4):571. PubMed ID: 31606743
[No Abstract] [Full Text] [Related]
2. Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
Madarame A; Kimura H; Kunisaki R
J Crohns Colitis; 2020 May; 14(4):569-570. PubMed ID: 31616911
[No Abstract] [Full Text] [Related]
3. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.
García Cámara P; Zubiri Ara ML; García López S
Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905
[No Abstract] [Full Text] [Related]
4. Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.
Nunes G; Patita M; Fernandes V
J Crohns Colitis; 2019 May; 13(6):812-813. PubMed ID: 30535292
[No Abstract] [Full Text] [Related]
5. Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Ganzleben I; Hirschmann S; Köhler J; Fuchs FS; Rieker RJ; Baer E; Klenske E; Nagore D; Neurath MF; Atreya R
Am J Gastroenterol; 2020 Apr; 115(4):632-634. PubMed ID: 32149778
[No Abstract] [Full Text] [Related]
6. Metastatic Cutaneous Crohn's Disease of the Face-A Case Successfully Treated With Ustekinumab.
Martins Figueiredo L; Oliveira AM; Martins A
J Crohns Colitis; 2020 Jul; 14(6):874-875. PubMed ID: 31630151
[No Abstract] [Full Text] [Related]
7. Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study.
de Risi-Pugliese T; Seksik P; Bouaziz JD; Chasset F; Moguelet P; Gornet JM; Bourrier A; Amiot A; Beaugerie L; Francès C; Guégan S;
J Am Acad Dermatol; 2019 Mar; 80(3):781-784. PubMed ID: 30003991
[No Abstract] [Full Text] [Related]
8. [Ustekinumab for the treatment of Crohn's disease -Indication of Ustekinumab according to efficacy and safety].
Ishihara S; Kawashima K; Kinoshita Y
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(3):216-223. PubMed ID: 30853674
[No Abstract] [Full Text] [Related]
9. Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.
Mugheddu C; Atzori L; Del Piano M; Lappi A; Pau M; Murgia S; Zucca I; Rongioletti F
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28833973
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab for treatment of cutaneous Crohn's disease.
Abdat R; Markova A; Farraye FA; Lichtman MK
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329588
[TBL] [Abstract][Full Text] [Related]
11. Is Ustekinumab the best treatment option in patients with Crohn's disease and coexistent multiple sclerosis?
Kapizioni C; Makris K; Kourkoulis P; Vrakas S; Michalopoulos G
Acta Gastroenterol Belg; 2019; 82(2):337. PubMed ID: 31314201
[No Abstract] [Full Text] [Related]
12. [A case of Crohn's disease complicated by Guillain-Barrè syndrome during ustekinumab therapy].
Fukushima T; Nakajima K; Nozawa H; Nishino H; Sugita A; Koganei K; Futatsuki R; Yamaguchi S; Asano S; Matsushima M
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(4):324-329. PubMed ID: 30971669
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease.
Huff-Hardy K; Bedair M; Vazquez R; Burstein E
Inflamm Bowel Dis; 2017 Oct; 23(10):E49. PubMed ID: 28858074
[No Abstract] [Full Text] [Related]
14. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
Cline A; Pichardo RO
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of Ustekinumab in Crohn's Disease with Severe Psoriasiform Rash Induced by Biotherapies in an Adolescent.
Bertrand V; El Haite A; Carré D
Pediatr Dermatol; 2017 Jul; 34(4):e214-e215. PubMed ID: 28436109
[TBL] [Abstract][Full Text] [Related]
16. Ustekinumab as Effective Treatment for Refractory Amicrobial Pustulosis of the Folds Associated with Crohn's Disease.
Al-Raddadi R; Frances C; Moguelet P; Bachmeyer C; Guégan S
Acta Derm Venereol; 2017 Mar; 97(3):389-390. PubMed ID: 27722763
[No Abstract] [Full Text] [Related]
17. Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
Harris KA; Horst S; Gadani A; Nohl A; Annis K; Duley C; Beaulieu D; Ghazi L; Schwartz DA
Inflamm Bowel Dis; 2016 Feb; 22(2):397-401. PubMed ID: 26752468
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent Crohn's uveitis with infliximab.
Ally MR; Veerappan GR; Koff JM
Am J Gastroenterol; 2008 Aug; 103(8):2150-1. PubMed ID: 18796120
[No Abstract] [Full Text] [Related]
19. Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
Ma C; Fedorak RN; Kaplan GG; Dieleman LA; Devlin SM; Stern N; Kroeker KI; Seow CH; Leung Y; Novak KL; Halloran BP; Huang VW; Wong K; Blustein PK; Ghosh S; Panaccione R
Inflamm Bowel Dis; 2017 May; 23(5):833-839. PubMed ID: 28328624
[TBL] [Abstract][Full Text] [Related]
20. Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.
Weaver KN; Gregory M; Syal G; Hoversten P; Hicks SB; Patel D; Christophi G; Beniwal-Patel P; Isaacs KL; Raffals L; Deepak P; Herfarth HH; Barnes EL
Inflamm Bowel Dis; 2019 Mar; 25(4):767-774. PubMed ID: 30295784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
